TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 18247193

Group type: COMPARATOR
Intervention: Fluoxetine (20 mg)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Eicosapentaenoic acid (EPA, 1000 mg)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Combination of EPA and fluoxetine
Number of subjects: 60
Study: 15865119

Group type: EXPERIMENTAL
Intervention: Underwater seal device
Number of subjects: 55

Group type: COMPARATOR
Intervention: Flutter valve drainage bag
Number of subjects: 55
Study: 14989113

Group type: EXPERIMENTAL
Intervention: Depigmented, polymerized extract of D. pteronyssinus and D. farinae
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control group (pharmacological treatment only)
Number of subjects: 22
Study: 10637145

Group type: EXPERIMENTAL
Intervention: Placement of a flap of pectineus fascia
Number of subjects: 37

Group type: COMPARATOR
Intervention: No flap of pectineus fascia (control)
Number of subjects: 37
Study: 8701396

Group type: EXPERIMENTAL
Intervention: n-3 polyunsaturated fatty acids (n-3 PUFA) 3 g daily
Number of subjects: 40

Group type: COMPARATOR
Intervention: corn oil (placebo)
Number of subjects: 40
Study: 1521779

Group type: EXPERIMENTAL
Intervention: Gc phenotype
Number of subjects: 258

Group type: EXPERIMENTAL
Intervention: AHSG phenotype
Number of subjects: 258
Study: 6430310

Group type: EXPERIMENTAL
Intervention: Sublingual buprenorphine (0.3 mg i.m. followed by 0.4 mg every 6 h for 3 days)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Intermittent morphine (10 mg i.m.)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Sublingual buprenorphine
Number of subjects: 80

Group type: COMPARATOR
Intervention: Intermittent morphine
Number of subjects: 80
Study: 31204885

Group type: EXPERIMENTAL
Intervention: Male contraceptive pill willingness
Number of subjects: 412
Study: 29193165

Group type: EXPERIMENTAL
Intervention: FX CorDiax dialyzer
Number of subjects: 10

Group type: COMPARATOR
Intervention: FX dialyzer
Number of subjects: 10
Study: 27505962

Group type: EXPERIMENTAL
Intervention: Seat fixed rotation manipulation (Group A)
Number of subjects: 170

Group type: EXPERIMENTAL
Intervention: Lateral position rotation manipulation (Group B)
Number of subjects: 170

Group type: EXPERIMENTAL
Intervention: Supine position rotation manipulation (Group C)
Number of subjects: 170
Study: 24270192

Group type: EXPERIMENTAL
Intervention: Follow-up by repeat cytology in primary care after initial BNA result, first test due 6 months after initial result.
Number of subjects: 621

Group type: EXPERIMENTAL
Intervention: Significant anxiety at recruitment, pain after follow-up cytology, having children, dissatisfaction with support received after initial BNA test.
Number of subjects: 621
Study: 22864310

Group type: EXPERIMENTAL
Intervention: Memory recognition test with previously unseen stimuli (fillers)
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Memory recognition test with previously seen stimuli (targets)
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Participants with low scores on a social avoidance measure
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Memory for negative stimuli
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Stimulus valence
Number of subjects: 2
Study: 20397454

Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 65

Group type: COMPARATOR
Intervention: Inositol (control)
Number of subjects: 65
Study: 17113190

Group type: EXPERIMENTAL
Intervention: Continuous etanercept therapy (50 mg once weekly)
Number of subjects: 2546

Group type: COMPARATOR
Intervention: Interrupted etanercept therapy (50 mg once weekly)
Number of subjects: 2546

Group type: EXPERIMENTAL
Intervention: Continuous etanercept therapy
Number of subjects: 2546

Group type: COMPARATOR
Intervention: Interrupted etanercept therapy
Number of subjects: 2546
Study: 16298925

Group type: EXPERIMENTAL
Intervention: Computer desktop‐based Virtual Reality (VR) street crossing training
Number of subjects: 19

Group type: COMPARATOR
Intervention: Computer based visual scanning tasks (Control)
Number of subjects: 19
Study: 12009350

Group type: EXPERIMENTAL
Intervention: Depot GnRH agonist followed by 17beta-estradiol transdermal patches (100 to 300 microg for at least 12 days)
Number of subjects: 296

Group type: COMPARATOR
Intervention: Endometrial preparation starting on day 1 of menstrual cycle with 200 microg increasing to 300 microg after 7 days
Number of subjects: 296
Study: 9657086

Group type: EXPERIMENTAL
Intervention: Wrist weight exercise (WW; n = 12)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: No-wrist weight exercise (NW; n = 11)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Non-exercise control (NE; n = 11)
Number of subjects: 23
Study: 7609299

Group type: EXPERIMENTAL
Intervention: Pirenzepine 10 mg
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Combination of pirenzepine 10 mg and famotidine 20 mg
Number of subjects: 52
Study: 2146229

Group type: EXPERIMENTAL
Intervention: Bubble oxygenator
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Membrane oxygenator
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Hybrid oxygenator
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Hollow fibre oxygenator
Number of subjects: 26

Group type: COMPARATOR
Intervention: All oxygenators
Number of subjects: 26
Study: 326594

Group type: EXPERIMENTAL
Intervention: 0.05% betamethasone 17,21-dipropionate cream
Number of subjects: 36

Group type: COMPARATOR
Intervention: 0.05% clobetasol propionate cream
Number of subjects: 36
Study: 31964428

Group type: EXPERIMENTAL
Intervention: Potato-based side dish
Number of subjects: 50

Group type: COMPARATOR
Intervention: Refined grain-based side dish
Number of subjects: 50
Study: 30519776

Group type: EXPERIMENTAL
Intervention: Vibrotactile feedback using a 'balance' belt worn around the waist for 1 month in daily life.
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Preselection trial of the 'balance' belt for 2 hours in the hospital.
Number of subjects: 39

Group type: COMPARATOR
Intervention: No intervention (control group).
Number of subjects: 39
Study: 28276741

Group type: EXPERIMENTAL
Intervention: Web-based self-management intervention (Kanker Nazorg Wijzer)
Number of subjects: 462

Group type: COMPARATOR
Intervention: Waiting list control group
Number of subjects: 462
Study: 25986136

Group type: EXPERIMENTAL
Intervention: Nurse-led hospital-based care transition intervention
Number of subjects: 700

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 700
Study: 23040657

Group type: EXPERIMENTAL
Intervention: Significant AKI (AKI stage 2 or 3)
Number of subjects: 218

Group type: COMPARATOR
Intervention: No AKI (AKI stage 0 or 1)
Number of subjects: 218

Group type: EXPERIMENTAL
Intervention: AKI group
Number of subjects: 218
Study: 22185726

Group type: EXPERIMENTAL
Intervention: Intravenous esmolol infusion
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control (saline infusion)
Number of subjects: 40
Study: 19061198

Group type: EXPERIMENTAL
Intervention: Viewing BOF before completing questionnaires
Number of subjects: 39

Group type: COMPARATOR
Intervention: Viewing BOF after completing questionnaires
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Viewing BOF after completing questionnaires (physicians)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Viewing BOF (all participants)
Number of subjects: 39
Study: 16310929

Group type: EXPERIMENTAL
Intervention: Initial IFN-alpha for 8 weeks (2 weeks 5x3x10(6)IU/wk; 2 weeks 5x6x10(6)IU/wk; 2 weeks 5x9x10(6)IU/wk; 2 weeks 3x9x10(6)IU/wk)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: IFN-alpha maintenance at 3x9x10(6)IU/wk after nephrectomy
Number of subjects: 16

Group type: COMPARATOR
Intervention: No intervention (progressive disease)
Number of subjects: 16
Study: 12775347

Group type: EXPERIMENTAL
Intervention: Quantitative EEG analysis (q-EEG) in OCD patients
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Quantitative EEG analysis (q-EEG) in OCD patients with higher scores in doubting test
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Quantitative EEG analysis (q-EEG) in severely ill OCD patients
Number of subjects: 0
Study: 11039921

Group type: EXPERIMENTAL
Intervention: Dawn signals (average illuminance 155 lux)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Control light (0.1 lux)
Number of subjects: 9
Study: 9109702

Group type: EXPERIMENTAL
Intervention: Fluticasone propionate 50 micrograms
Number of subjects: 342

Group type: EXPERIMENTAL
Intervention: Fluticasone propionate 100 micrograms
Number of subjects: 342

Group type: EXPERIMENTAL
Intervention: Fluticasone propionate 250 micrograms
Number of subjects: 342

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 342

Group type: EXPERIMENTAL
Intervention: Fluticasone propionate (all doses)
Number of subjects: 342
Study: 8464394

Group type: EXPERIMENTAL
Intervention: 200 micrograms nocloprost (solved in 50 cc water)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study: 3096261

Group type: EXPERIMENTAL
Intervention: Total parenteral nutrition (TPN)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Control group (no TPN)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: TPN
Number of subjects: 14
Study: 30856111

Group type: EXPERIMENTAL
Intervention: Very high comorbidity
Number of subjects: 362

Group type: EXPERIMENTAL
Intervention: Each further comorbidity
Number of subjects: 362

Group type: COMPARATOR
Intervention: High comorbidity
Number of subjects: 362

Group type: COMPARATOR
Intervention: Low comorbidity
Number of subjects: 362
Study: 28954544

Group type: EXPERIMENTAL
Intervention: EMPOWER intervention (social cognitive theory intervention)
Number of subjects: 57

Group type: COMPARATOR
Intervention: Healthy Lifestyles intervention (knowledge-based intervention)
Number of subjects: 57
Study: 27282308

Group type: EXPERIMENTAL
Intervention: Intercostal muscle flap harvesting and pericostal no‐compression 'edge' suture (IMF group)
Number of subjects: 297

Group type: COMPARATOR
Intervention: Standard suture technique with intrapleural intercostal nerve block (IINB group)
Number of subjects: 297
Study: 24219814

Group type: EXPERIMENTAL
Intervention: Nebulized tobramycin 300 mg twice a day (TNS)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Intravenous tobramycin (IV)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Nebulized tobramycin (TNS)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 20
Study: 21979491

Group type: EXPERIMENTAL
Intervention: Probiotic treatment (Lactobacillus rhamnosus LPR and Bifidobacterium longum BL999) in Finnish infants
Number of subjects: 162

Group type: COMPARATOR
Intervention: Placebo treatment in Finnish infants
Number of subjects: 162

Group type: EXPERIMENTAL
Intervention: Probiotic treatment in German infants
Number of subjects: 162

Group type: COMPARATOR
Intervention: Breast-fed infants (control group)
Number of subjects: 162
Study: 20880093

Group type: EXPERIMENTAL
Intervention: Sirolimus (SRL)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Mycophenolate mofetil (MMF)
Number of subjects: 20
Study: 18926162

Group type: EXPERIMENTAL
Intervention: 10% glucose/insulin infusion
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Intralipid plus heparin infusion
Number of subjects: 12

Group type: COMPARATOR
Intervention: Saline infusion
Number of subjects: 12
Study: 15894970

Group type: EXPERIMENTAL
Intervention: Tirofiban
Number of subjects: 4623

Group type: COMPARATOR
Intervention: Abciximab
Number of subjects: 4623

Group type: EXPERIMENTAL
Intervention: Tirofiban and Abciximab
Number of subjects: 4623
Study: 12360590

Group type: EXPERIMENTAL
Intervention: CPAP-therapy (REMstar Choice, Respironics, USA)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo (nasal mask without turning on the apparatus)
Number of subjects: 12
Study: 10195548

Group type: EXPERIMENTAL
Intervention: Laryngeal mask airway (LMA)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Cuffed oropharyngeal airway (COPA)
Number of subjects: 60
Study: 7782140

Group type: EXPERIMENTAL
Intervention: Verapamil
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 2101170

Group type: EXPERIMENTAL
Intervention: Controlled release naproxen (750 mg/day for 10-15 days)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Standard naproxen (two 375 mg/day capsules for 10-15 days)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Controlled release naproxen
Number of subjects: 48

Group type: COMPARATOR
Intervention: Standard naproxen
Number of subjects: 48
Study: 10249458

Group type: EXPERIMENTAL
Intervention: Crisis intervention (two different intensities)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 30
Study: 30041568

Group type: EXPERIMENTAL
Intervention: Mixed-methods (MM; PACKS and SLURRY concurrently)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Ice slurry ingestion (SLURRY)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Ice-packs placed on the quadriceps and hamstrings (PACKS)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 8
Study: 28564557

Group type: EXPERIMENTAL
Intervention: Minocycline (100 mg orally twice daily)
Number of subjects: 142

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 142
Study: 27180352

Group type: EXPERIMENTAL
Intervention: 1-step self-etch adhesive (1-SEA)
Number of subjects: 200

Group type: COMPARATOR
Intervention: 3-step etch-and-rinse adhesive (3-E&RA)
Number of subjects: 200
Study: 23742202

Group type: EXPERIMENTAL
Intervention: Medicalized counseling video (by an endocrinologist)
Number of subjects: 89

Group type: COMPARATOR
Intervention: Demedicalized counseling video (by a psychologist)
Number of subjects: 89
Study: 21848448

Group type: EXPERIMENTAL
Intervention: Botulinum toxin type B (BTX‐B) injections on one side of the face
Number of subjects: 15

Group type: COMPARATOR
Intervention: Saline control injections on the other side of the face
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Overall self-assessment and objective mexameter evaluation
Number of subjects: 15
Study: 19135077

Group type: COMPARATOR
Intervention: Composite paradigm intervention for face processing
Number of subjects: 0
Study: 17244149

Group type: EXPERIMENTAL
Intervention: Resin coating with Clearfil Protect Bond (PB) and Protect Liner F (PLF)
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Direct composite restorations with PB
Number of subjects: 5

Group type: COMPARATOR
Intervention: Control group with uncoated cavity surfaces
Number of subjects: 5
Study: 14756461

Group type: EXPERIMENTAL
Intervention: Microencapsulated timothy grass pollen extract
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 11704311

Group type: COMPARATOR
Intervention: XRT
Number of subjects: 146

Group type: EXPERIMENTAL
Intervention: A + XRT
Number of subjects: 146
Study: 9144684

Group type: EXPERIMENTAL
Intervention: Paclitaxel (Taxol) 175 mg/m2 followed by cisplatin 80 mg/m2
Number of subjects: 332

Group type: COMPARATOR
Intervention: Cisplatin 80 mg/m2 followed by teniposide (Vumon) 100 mg/m2
Number of subjects: 332

Group type: COMPARATOR
Intervention: Cisplatin/teniposide
Number of subjects: 332

Group type: EXPERIMENTAL
Intervention: Paclitaxel/cisplatin
Number of subjects: 332
Study: 9316683

Group type: EXPERIMENTAL
Intervention: Nimodipine (90 mg q.d.)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Nimodipine
Number of subjects: 66
Study: 3234468

Group type: EXPERIMENTAL
Intervention: Amitriptyline 75 mg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Amitriptyline 75 mg with Diazepam 10 mg
Number of subjects: 12

Group type: COMPARATOR
Intervention: Diazepam 10 mg
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 31092019

Group type: EXPERIMENTAL
Intervention: Non-dipper group (systolic BP decline <10%)
Number of subjects: 449

Group type: COMPARATOR
Intervention: Dipper-dipper group (systolic BP decline 10% or more)
Number of subjects: 449
Study: 28550377

Group type: EXPERIMENTAL
Intervention: Tenofovir 1% gel
Number of subjects: 91

Group type: COMPARATOR
Intervention: Hydroxycellulose (HEC) placebo gel
Number of subjects: 91
Study: 27871242

Group type: EXPERIMENTAL
Intervention: Statin therapy for 12 months
Number of subjects: 69
Study: 25183661

Group type: EXPERIMENTAL
Intervention: Methylphenidate modified-release long-acting formulation (MPH-LA) at 20 mg/day, up-titrated to 40-80 mg/day
Number of subjects: 298

Group type: EXPERIMENTAL
Intervention: Methylphenidate modified-release long-acting formulation (MPH-LA)
Number of subjects: 298
Study: 23169362

Group type: EXPERIMENTAL
Intervention: Pentoxifylline (PTX) 400mg/day for 6 months
Number of subjects: 100

Group type: COMPARATOR
Intervention: Losartan and enalapril (Control)
Number of subjects: 100
Study: 20808923

Group type: EXPERIMENTAL
Intervention: Amodiaquine & Artesunate (AS+AQ) monthly
Number of subjects: 2451

Group type: EXPERIMENTAL
Intervention: Amodiaquine & Artesunate (AS+AQ) bimonthly
Number of subjects: 2451

Group type: EXPERIMENTAL
Intervention: Sulphadoxine-Pyrimethamine (SP) bimonthly
Number of subjects: 2451

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2451
Study: 17511193

Group type: EXPERIMENTAL
Intervention: 0.05% betamethasone gel
Number of subjects: 100

Group type: COMPARATOR
Intervention: KY gel
Number of subjects: 100
Study: 16014845

Group type: EXPERIMENTAL
Intervention: Combined therapy (DEC/ALB)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Albendazole (ALB)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: DEC/ALB
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Diethylcarbamazine (DEC)
Number of subjects: 0
Study: 12442883

Group type: EXPERIMENTAL
Intervention: Amisulpride (200-800 mg/d)
Number of subjects: 377

Group type: COMPARATOR
Intervention: Olanzapine (5-20 mg/d)
Number of subjects: 377
Study: 10193779

Group type: EXPERIMENTAL
Intervention: TASP-V (10 microg kg(‐1) intranasal pretreatment)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: TASP-V analogue (10 microg kg(‐1) aerosolized pretreatment)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: TASP-V analogue (20 microg kg(‐1) aerosolized pretreatment)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: TASP-V (1.275 microg kg(‐1) intranasal pretreatment)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 20
Study: 7738436

Group type: EXPERIMENTAL
Intervention: Colored overlays or lenses (e.g., Irlen lenses)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Clear and chromatic lenses
Number of subjects: 8
Study: 2405616

Group type: COMPARATOR
Intervention: Nifedipine (20 mg three times daily)
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: Nicardipine (30 mg three times daily)
Number of subjects: 250
Study: 6107945

Group type: EXPERIMENTAL
Intervention: DL-308 (10 mg)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: DL-308 (20 mg)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Thioridazine (50 mg)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: DL-308 (10 mg) vs Thioridazine (50 mg)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: DL-308 (10 mg) and Thioridazine (50 mg)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: DL-308 and Thioridazine
Number of subjects: 8
Study: 31649946

Group type: EXPERIMENTAL
Intervention: Complex breathlessness intervention
Number of subjects: 50

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 50
Study: 28588793

Group type: EXPERIMENTAL
Intervention: L-Glutamine (10 g orally three times daily)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: L-Glutamine
Number of subjects: 50
Study: 26109814

Group type: EXPERIMENTAL
Intervention: Autologous CD34(+) cell infusion
Number of subjects: 45

Group type: COMPARATOR
Intervention: Standard of care treatment for liver cirrhosis
Number of subjects: 45
Study: 24918558

Group type: EXPERIMENTAL
Intervention: 1% E‐BPO
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: 5% E‐BPO
Number of subjects: 92

Group type: COMPARATOR
Intervention: Vehicle
Number of subjects: 92
Study: 23063301

Group type: EXPERIMENTAL
Intervention: eszopiclone 1mg
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: eszopiclone 2mg
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: eszopiclone 3mg
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: zolpidem 10mg
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: eszopiclone (all doses)
Number of subjects: 72

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 72
Study: 19242916

Group type: EXPERIMENTAL
Intervention: Restorative yoga (RY) intervention (10 weekly 75-minute classes)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 44
Study: 17603387

Group type: EXPERIMENTAL
Intervention: Navigation system
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Computed tomography plan method
Number of subjects: 20

Group type: COMPARATOR
Intervention: Conventional method
Number of subjects: 20

Group type: COMPARATOR
Intervention: Conventional method first
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Navigation
Number of subjects: 20
Study: 15007319

Group type: EXPERIMENTAL
Intervention: Intra-articular ketamine (0.5 mg/kg)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Intra-articular neostigmine
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Intra-articular bupivacaine
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 11247525

Group type: EXPERIMENTAL
Intervention: Keys to Caregiving program delivered by 6-weekly visits
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control program consisting of 6-weekly neutral visits
Number of subjects: 0
Study: 10868163

Group type: EXPERIMENTAL
Intervention: Stimulants
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Psychosocial treatments
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Long-term studies
Number of subjects: 0

Group type: COMPARATOR
Intervention: Psychostimulants
Number of subjects: 0
Study: 8021573

Group type: EXPERIMENTAL
Intervention: Felodipine 10-20 mg once daily for four weeks
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study: 2561594

Group type: EXPERIMENTAL
Intervention: Enalapril
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 779718

Group type: EXPERIMENTAL
Intervention: Lofepramine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Imipramine
Number of subjects: 0
Study: 31815726

Group type: EXPERIMENTAL
Intervention: CT-ultrasound fusion imaging (n=7)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Traditional X-ray fluoroscopy (n=7)
Number of subjects: 14
Study: 30783858

Group type: EXPERIMENTAL
Intervention: RENEW intervention (home-based diet and exercise)
Number of subjects: 641